Showing 11-15 of 68 news & articles:
Five Leading Real-World Data and Analytics Organizations Join the RWE Alliance, Doubling Membership

Real-World Evidence Alliance Online Read the Full Article>> Washington, D.C. (April 5, 2022) – The RWE Alliance is pleased to announce the addition of five new members—ConcertAI, OM1, Syneos Health, Verana Health, and Verily—to continue to advance policies to support regulatory use of real-world evidence (RWE). The RWE Alliance is a policy and advocacy coalition of real-world data (RWD) and analytics organizations with[…]

A new approach for post-marketing safety studies

BioPharma Dive Online April 4, 2022 Read the Full Article >>   The large quantity of digitized healthcare data in the U.S., combined with advancements in data collection and processing technologies, present an enormous opportunity to shift dramatically how post-marketing safety studies can and should be conducted. The Traditional Approach Post-marketing safety studies are a[…]

OM1 Launches New Mental Health and Neuroscience Real-World Data Network

Read the Press Release>>   BOSTON, March 31, 2022 /PRNewswire/ — OM1, a leading technology enabled real-world data and artificial intelligence (AI) company with a focus on delivering insights into multiple chronic diseases, today announces the launch of its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur, Dr. Carl D. Marci. The division includes new data on psychiatric[…]

Real-World Data Delivers Dose of Hope for Mental Health in the U.S.

Pharmaceutical Executive Online Published: March 15, 2022 Read the Full Article >> If you were asked which health care conditions rank as the highest in both unmet need and in cost, which would you choose? Would it be cancer or heart disease? While those conditions certainly place in both categories, mental health outranks them in[…]

Real-World Data + AI: Bridging the Gap from Population to Personalization

Inside Precision Medicine Online Published: February 16, 2022 Read the Full Article >>   Personalizing medicine using population-level insights can seem like a contradiction. On one hand, the goal is to better fit treatment to the individual patient, moving away from generalized approaches toward a “one size fits all” model.  On the other, we have[…]